Jefferson Health in Philadelphia is suing Aetna over a new Medicare Advantage payment policy that hospitals say unfairly reduces reimbursements for legitimate inpatient stays. The case highlights a broader clash between providers and Medicare Advantage plans over “downcoding” short hospital stays and controlling costs. The post Jefferson Health Sues Aetna As Providers’ Frustration with MA…
Rural health organizations cannot afford to get dazzled by AI demo candy. There is no such thing as “FixHealthcareGPT,” and investing in the wrong technology for the future isn’t going to do anything to improve patient outcomes today. The post Rural Healthcare Transformation Has to Focus on the Real World, Not Techno-Fantasies appeared first on…
Consumers are inundated with false information circulating online about GLP-1 medicines, which causes confusion and can lead to potentially serious health problems resulting from dosing errors and adverse reactions to ingredients in compounded GLP-1 products. The post It’s Time to Put Guardrails on GLP-1 Compounding appeared first on MedCity News.
[Sponsored] Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems. The post The Power Behind Enterprise EHR Software for Large Healthcare Systems appeared first on MedCity News.
Healthcare leaders can’t tell whether value-based care and Medicare Advantage are truly lowering costs. Some see promise in these models and ongoing innovations, while others say the programs haven’t delivered measurable savings and point to direct contracting as a more transparent way to control spending. The post Do Healthcare CEOs Agree on Whether VBC and…
Gilead Sciences’ Tubulis acquisition brings antibody drug conjugates in clinical development for cancer. Analysts say the Tubulis platform technologies that yielded these ADCs could also help Gilead develop drugs in other therapeutic areas. The post Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis appeared first on MedCity News.
When revenue cycle partners wait to be asked, or rely on “tell us what you need” as a default, they miss critical opportunities to deliver meaningful performance, support their client organizations, and ultimately serve patients better. In today’s healthcare environment, partnership requires anticipation, not reaction. The post Stop Waiting to Be Asked: What Operators Really…
Today’s technology has the potential to empower independent pharmacies to offer adherence support at a greater scale — and healthcare engagements that overlook this touchpoint miss out. The post How Tech-Enabled Independent Pharmacies Can Address America’s Medication Adherence Crisis appeared first on MedCity News.
Innovation in women’s health technology is about improving input data, refining performance criteria and ensuring design assumptions align with biological reality and real-world usage. When those fundamentals are in place, products are more accurate, more trustworthy and more likely to be adopted by clinicians and consumers alike. The post Women’s Health Is Central to the…
Digital health funding rebounded in the first quarter of 2026, reaching $4 billion across 110 deals, according to data from Rock Health. The surge was fueled mainly by megadeals, reflecting a market where investors are placing larger bets on fewer startups. The post Digital Health Startups Raised $4B in Q1: How Cash Is Flowing Amid…